Alkermes Plc (ALKS)

Jul 09, 2026

ALKS Stock Surges 15% On Lilly-Centessa Buyout Igniting Sleep Pipeline Hopes - Stocktwits

Jul 09, 2026

Jul 08, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 08, 2026

Jul 08, 2026

Alkermes plc Files 8-K Termination Report: Company Overview, NASDAQ Listing, and Key Details (July 2026) - Minichart

Jul 08, 2026

Jul 07, 2026

Enterprise value to EBITDA forward of Alkermes plc – NASDAQ:ALKS - TradingView

Jul 07, 2026

Jul 07, 2026

Alkermes plc outlines its role in neuroscience therapies as a global biopharmaceutical company - AD HOC NEWS

Jul 07, 2026

Jul 06, 2026

Insider Sell: David Gaffin Sells Shares of Alkermes PLC - GuruFocus

Jul 06, 2026

Jul 06, 2026

ALKS News | ALKERMES PLC (NASDAQ:ALKS) - ChartMill

Jul 06, 2026

Jul 06, 2026

Alkermes stock hits 52-week high at 55.28 USD By Investing.com - Investing.com South Africa

Jul 06, 2026

Jul 06, 2026

Alkermes stock hits 52-week high at 55.28 USD - Investing.com

Jul 06, 2026

Jul 06, 2026

Alkermes (ALKS) EVP David Gaffin sells 2,034 shares under 10b5-1 plan - Stock Titan

Jul 06, 2026

Jul 06, 2026

Alkermes plc (ALKS) notice: David Gaffin lists proposed Common Stock sales in 2026 - Stock Titan

Jul 06, 2026

Jul 06, 2026

Price to earnings forward of Alkermes plc – NASDAQ:ALKS - TradingView

Jul 06, 2026

Jul 06, 2026

Granules India secures sole First-to-File status for generic drug - The Times of India

Jul 06, 2026

Jul 05, 2026

ALKSAlkermes plc Volatility & Greeks - Finviz

Jul 05, 2026

Jul 05, 2026

(ALKS) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jul 05, 2026

Jul 04, 2026

The Bull Case For Alkermes (ALKS) Could Change Following Vibrance-12 Data And Russell 2000 Inclusion - simplywall.st

Jul 04, 2026

Jul 02, 2026

ALKS Maintains Rating by Mizuho -- Price Target Raised to $65 - GuruFocus

Jul 02, 2026

Jul 02, 2026

Mizuho raises Alkermes stock price target to $65 on narcolepsy drug potential - Investing.com

Jul 02, 2026

Jul 01, 2026

Alkermes (ALKS) R&D chief exercises 5,000 options and sells 9,000 shares - Stock Titan

Jul 01, 2026

Jul 01, 2026

Alkermes (ALKS) shows multiple 9,000-share insider sales, exercise and vesting - Stock Titan

Jul 01, 2026

Jun 30, 2026

Alkermes (ALKS) Is Up 9.3% After Strong Alixorexton Phase 2 Data And Russell 2000 AdditionWhat's Changed - Yahoo Finance

Jun 30, 2026

Jun 29, 2026

A Look at Alkermes PLC (ALKS) After 4.8% Decline -- GF Value $31 - GuruFocus

Jun 29, 2026

Jun 29, 2026

Alkermes plummets on mid-stage Alixorexton data for narcolepsy - MSN

Jun 29, 2026

Jun 29, 2026

ALKS Maintained by Wells Fargo -- Price Target Raised to $65.00 - GuruFocus

Jun 29, 2026

Jun 29, 2026

ALKS Downgraded by B of A Securities -- Rating Changed to Underp - GuruFocus

Jun 29, 2026

Jun 29, 2026

BofA downgrades Alkermes stock rating on valuation concerns By Investing.com - Investing.com Australia

Jun 29, 2026

Jun 29, 2026

BofA downgrades Alkermes stock rating on valuation concerns - Investing.com

Jun 29, 2026

Jun 29, 2026

REGBlackRock GroupSAR 6ALKERMES PLC - TradingView

Jun 29, 2026

Jun 28, 2026

Enterprise value to EBIT forward of Alkermes plc – NASDAQ:ALKS - TradingView

Jun 28, 2026

Jun 28, 2026

Press Release: Alkermes to Report First Quarter Financial Results on May 5, 2026 - Moomoo

Jun 28, 2026

Jun 27, 2026

Price to sales forward of Alkermes plc – NASDAQ:ALKS - TradingView

Jun 27, 2026

Jun 26, 2026

Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda - BioPharma Dive

Jun 26, 2026

Jun 26, 2026

What Does the Recent Insider Sale by Alkermes' VP of Finance Signify - Kavout | AI

Jun 26, 2026

Jun 25, 2026

Alkermes Public Limited Company Actuals & Estimates (NASDAQ:ALKS) - TradingView

Jun 25, 2026

Jun 25, 2026

ALKS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Alkermes stock hits 52-week high at 51.77 USD By Investing.com - Investing.com South Africa

Jun 25, 2026

Jun 25, 2026

Alkermes stock hits 52-week high at 51.77 USD - Investing.com

Jun 25, 2026

Jun 24, 2026

Liquidity Mapping Around (ALKS) Price Events - Stock Traders Daily

Jun 24, 2026

Jun 24, 2026

Alkermes Jumps 6.9% After Needham Maintains Buy - AlphaStreet

Jun 24, 2026

Jun 24, 2026

ALKS Maintained by Needham -- Price Target Raised to $61.00 - GuruFocus

Jun 24, 2026

Jun 23, 2026

Alkermes PLC (ALKS) Shares Surge 4.3% -- What GF Score of 70 Tel - GuruFocus

Jun 23, 2026

Jun 23, 2026

ALKS Maintained by TD Cowen -- Price Target Raised to $50 - GuruFocus

Jun 23, 2026

Jun 22, 2026

Alkermes plc (ALKS) Stock Analysis: Navigating Growth in Biopharmaceuticals with a 4.88% Upside - DirectorsTalk Interviews

Jun 22, 2026

Jun 22, 2026

Alkermes Plc (ALKS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026

Jun 21, 2026

Alkermes presents detailed positive results from Vibrance-2 phase 2 study of Alixorexton in adults with narcolepsy type 2 at SLEEP 2026 - MSN

Jun 21, 2026

Jun 19, 2026

Alkermes announces orphan drug designations for Alixorexton in the US and Europe - MSN

Jun 19, 2026

Jun 19, 2026

Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS) - Seeking Alpha

Jun 19, 2026

Jun 19, 2026

Did Positive Vibrance-2 Data for Alixorexton Just Shift Alkermes' (ALKS) Investment Narrative? - simplywall.st

Jun 19, 2026

Jun 19, 2026

Alkermes stock hits 52-week high at 45.76 USD By Investing.com - Investing.com India

Jun 19, 2026